Literature DB >> 16310055

Asymptomatic neurocutaneous melanocytosis in patients with large congenital melanocytic nevi: a study of cases from an Internet-based registry.

Anna Liza C Agero1, Cristiane Benvenuto-Andrade, Stephen W Dusza, Allan C Halpern, Ashfaq A Marghoob.   

Abstract

BACKGROUND: Recent retrospective studies using magnetic resonance imaging (MRI) to screen for neurocutaneous melanocytosis (NCM) among neurologically asymptomatic children with large congenital melanocytic nevi (LCMN) report high prevalence (23-30%) of asymptomatic NCM. We sought to determine prevalence of asymptomatic NCM, and current application of MRI as a screening tool.
METHODS: Patients with LCMN from an Internet-based registry answered a questionnaire regarding NCM status.
RESULTS: Of 379 patients with LCMN, 26 reportedly had NCM, with 17 reporting neurologic symptoms. Of 186 patients undergoing MRI, 9 reported abnormal findings without neurologic symptoms (4.8%); 80% had LCMN on the posterior axis, whereas 55% had more than 20 satellite nevi. LIMITATIONS: Study data rely on the registry members' self-reported findings and are limited by lack of independent data verification.
CONCLUSION: Asymptomatic NCM (determined by MRI) may not be common, with much lower prevalence (4.8%) than previously reported. MRI is widely used for screening patients at risk for NCM, such as patients with LCMN involving the posterior axis and greater than 20 satellite nevi.

Entities:  

Mesh:

Year:  2005        PMID: 16310055     DOI: 10.1016/j.jaad.2005.07.046

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

1.  Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy.

Authors:  Yibing Ruan; Anna Kovalchuk; Aarthi Jayanthan; Xueqing Lun; Yoji Nagashima; Olga Kovalchuk; James R Wright; Alfredo Pinto; Adam Kirton; Ronald Anderson; Aru Narendran
Journal:  Neuro Oncol       Date:  2014-11-12       Impact factor: 12.300

Review 2.  [New aspects of congenital melanocytic nevi].

Authors:  S Krengel
Journal:  Hautarzt       Date:  2012-02       Impact factor: 0.751

Review 3.  A giant congenital melanocytic nevus associated with neurocutaneous melanosis.

Authors:  S J Kim; J-H Kim; B Son; C Yoo
Journal:  Clin Neuroradiol       Date:  2013-10-31       Impact factor: 3.649

4.  Ultrasonographic detection of intracranial melanocytosis in an infant.

Authors:  Jason M Johnson; L Leigh Patten; Caroline D Robson; Rita L Teele
Journal:  Pediatr Radiol       Date:  2009-09-09

5.  Giant Congenital Melanocytic Nevus of the Buttock.

Authors:  Andrew A Marano; Adam M Feintisch; Ramazi Datiashvili
Journal:  Eplasty       Date:  2015-06-17

6.  Neurocutaneous melanocytosis (melanosis).

Authors:  Martino Ruggieri; Agata Polizzi; Stefano Catanzaro; Manuela Lo Bianco; Andrea D Praticò; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-10-13       Impact factor: 1.475

7.  New insights into neurocutaneous melanosis.

Authors:  Ketsuda Jakchairoongruang; Yasmin Khakoo; Mark Beckwith; A James Barkovich
Journal:  Pediatr Radiol       Date:  2018-08-03

Review 8.  Neurocutaneous melanosis and the Dandy-Walker complex: an uncommon but not so insignificant association.

Authors:  Dominique Marnet; Matthieu Vinchon; Keyvan Mostofi; Benoit Catteau; Olivier Kerdraon; Patrick Dhellemmes
Journal:  Childs Nerv Syst       Date:  2009-08-27       Impact factor: 1.475

9.  [Therapy of congenital melanocytic nevi. Excision, dermabrasion, laser].

Authors:  B Konz
Journal:  Hautarzt       Date:  2007-08       Impact factor: 0.751

10.  Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.

Authors:  Veronica A Kinsler; Anna C Thomas; Miho Ishida; Neil W Bulstrode; Sam Loughlin; Sandra Hing; Jane Chalker; Kathryn McKenzie; Sayeda Abu-Amero; Olga Slater; Estelle Chanudet; Rodger Palmer; Deborah Morrogh; Philip Stanier; Eugene Healy; Neil J Sebire; Gudrun E Moore
Journal:  J Invest Dermatol       Date:  2013-02-07       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.